Cargando…
Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis
OBJECTIVE: To compare the 5-year overall survival (OS) and disease-free survival (DFS) of patients with cervical cancer who received neoadjuvant chemotherapy followed by surgery (NACT) with those who received abdominal radical hysterectomy alone (ARH). METHODS: We retrospectively compared the oncolo...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473821/ https://www.ncbi.nlm.nih.gov/pubmed/34589433 http://dx.doi.org/10.3389/fonc.2021.730753 |
_version_ | 1784575078507216896 |
---|---|
author | Li, Weili Zhang, Wenling Sun, Lixin Wang, Li Cui, Zhumei Zhao, Hongwei Wang, Danbo Zhang, Yi Guo, Jianxin Yang, Ying Wang, Wuliang Bin, Xiaonong Lang, Jinghe Liu, Ping Chen, Chunlin |
author_facet | Li, Weili Zhang, Wenling Sun, Lixin Wang, Li Cui, Zhumei Zhao, Hongwei Wang, Danbo Zhang, Yi Guo, Jianxin Yang, Ying Wang, Wuliang Bin, Xiaonong Lang, Jinghe Liu, Ping Chen, Chunlin |
author_sort | Li, Weili |
collection | PubMed |
description | OBJECTIVE: To compare the 5-year overall survival (OS) and disease-free survival (DFS) of patients with cervical cancer who received neoadjuvant chemotherapy followed by surgery (NACT) with those who received abdominal radical hysterectomy alone (ARH). METHODS: We retrospectively compared the oncological outcomes of 1410 patients with stage IB3 cervical cancer who received NACT (n=583) or ARH (n=827). The patients in the NACT group were divided into an NACT-sensitive group and an NACT-insensitive group according to their response to chemotherapy. RESULTS: The 5-year oncological outcomes were significantly better in the NACT group than in the ARH group (OS: 96.2% vs. 91.2%, respectively, p=0.002; DFS: 92.2% vs. 87.5%, respectively, p=0.016). Cox multivariate analysis suggested that NACT was independently associated with a better 5-year OS (HR=0.496; 95% CI, 0.281-0.875; p=0.015), but it was not an independent factor for 5-year DFS (HR=0.760; 95% CI, 0.505-1.145; p=0.189). After matching, the 5-year oncological outcomes of the NACT group were better than those of the ARH group. Cox multivariate analysis suggested that NACT was still an independent protective factor for 5-year OS (HR=0.503; 95% CI, 0.275-0.918; p=0.025). The proportion of patients in the NACT group who received postoperative radiotherapy was significantly lower than that in the ARH group (p<0.001). Compared to the ARH group, the NACT-sensitive group had similar results as the NACT group. The NACT-insensitive group and the ARH group had similar 5-year oncological outcomes and proportions of patients receiving postoperative radiotherapy. CONCLUSION: Among patients with stage IB3 cervical cancer, NACT improved 5-year OS and was associated with a reduction in the proportion of patients receiving postoperative radiotherapy. These findings suggest that patients with stage IB3 cervical cancer, especially those who are sensitive to chemotherapy, might consider NACT followed by surgery. |
format | Online Article Text |
id | pubmed-8473821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84738212021-09-28 Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis Li, Weili Zhang, Wenling Sun, Lixin Wang, Li Cui, Zhumei Zhao, Hongwei Wang, Danbo Zhang, Yi Guo, Jianxin Yang, Ying Wang, Wuliang Bin, Xiaonong Lang, Jinghe Liu, Ping Chen, Chunlin Front Oncol Oncology OBJECTIVE: To compare the 5-year overall survival (OS) and disease-free survival (DFS) of patients with cervical cancer who received neoadjuvant chemotherapy followed by surgery (NACT) with those who received abdominal radical hysterectomy alone (ARH). METHODS: We retrospectively compared the oncological outcomes of 1410 patients with stage IB3 cervical cancer who received NACT (n=583) or ARH (n=827). The patients in the NACT group were divided into an NACT-sensitive group and an NACT-insensitive group according to their response to chemotherapy. RESULTS: The 5-year oncological outcomes were significantly better in the NACT group than in the ARH group (OS: 96.2% vs. 91.2%, respectively, p=0.002; DFS: 92.2% vs. 87.5%, respectively, p=0.016). Cox multivariate analysis suggested that NACT was independently associated with a better 5-year OS (HR=0.496; 95% CI, 0.281-0.875; p=0.015), but it was not an independent factor for 5-year DFS (HR=0.760; 95% CI, 0.505-1.145; p=0.189). After matching, the 5-year oncological outcomes of the NACT group were better than those of the ARH group. Cox multivariate analysis suggested that NACT was still an independent protective factor for 5-year OS (HR=0.503; 95% CI, 0.275-0.918; p=0.025). The proportion of patients in the NACT group who received postoperative radiotherapy was significantly lower than that in the ARH group (p<0.001). Compared to the ARH group, the NACT-sensitive group had similar results as the NACT group. The NACT-insensitive group and the ARH group had similar 5-year oncological outcomes and proportions of patients receiving postoperative radiotherapy. CONCLUSION: Among patients with stage IB3 cervical cancer, NACT improved 5-year OS and was associated with a reduction in the proportion of patients receiving postoperative radiotherapy. These findings suggest that patients with stage IB3 cervical cancer, especially those who are sensitive to chemotherapy, might consider NACT followed by surgery. Frontiers Media S.A. 2021-09-13 /pmc/articles/PMC8473821/ /pubmed/34589433 http://dx.doi.org/10.3389/fonc.2021.730753 Text en Copyright © 2021 Li, Zhang, Sun, Wang, Cui, Zhao, Wang, Zhang, Guo, Yang, Wang, Bin, Lang, Liu and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Li, Weili Zhang, Wenling Sun, Lixin Wang, Li Cui, Zhumei Zhao, Hongwei Wang, Danbo Zhang, Yi Guo, Jianxin Yang, Ying Wang, Wuliang Bin, Xiaonong Lang, Jinghe Liu, Ping Chen, Chunlin Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis |
title | Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis |
title_full | Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis |
title_fullStr | Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis |
title_full_unstemmed | Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis |
title_short | Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis |
title_sort | neoadjuvant chemotherapy followed by surgery versus abdominal radical hysterectomy alone for oncological outcomes of stage ib3 cervical cancer—a propensity score matching analysis |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473821/ https://www.ncbi.nlm.nih.gov/pubmed/34589433 http://dx.doi.org/10.3389/fonc.2021.730753 |
work_keys_str_mv | AT liweili neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT zhangwenling neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT sunlixin neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT wangli neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT cuizhumei neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT zhaohongwei neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT wangdanbo neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT zhangyi neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT guojianxin neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT yangying neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT wangwuliang neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT binxiaonong neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT langjinghe neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT liuping neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis AT chenchunlin neoadjuvantchemotherapyfollowedbysurgeryversusabdominalradicalhysterectomyaloneforoncologicaloutcomesofstageib3cervicalcancerapropensityscorematchinganalysis |